Pay in 4 interest-free payments of $6.07 Learn more
Ships within 48 hours · Estimated delivery Sep 23 - Sep 28
About 1017% of Wegovy users experience them
General Laboratory Controls No Personal Use Do not administer to humans or animals and do not use outside a controlled research setting
Clinical trials (SURPASS program) have demonstrated that tirzepatide produces substantial reductions in hemoglobin A1c (HbA1c), with decreases ranging from 1.9% to 2.6% depending on the dose used
Doctor-guided care Licensed providers design thoughtful titration plans, check in regularly, and fine-tune your plan along the way
*Ozempic and Mounjaro are primarily approved for type 2 diabetes in many countries, while Wegovy and Zepbound are specifically approved for chronic weight management
US$ 25.11
US$ 21.75
US$ 26.75
